Literature DB >> 20592149

Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.

K Amsler1, C Santoro, B Foleno, K Bush, R Flamm.   

Abstract

The susceptibility of 513 clinical isolates to doripenem was determined by broth microdilution, agar dilution, and Etest. Overall agreements for Etest and agar dilution MIC values compared to reference broth microdilution at +/-1 log(2) dilution were 88% and 94%, respectively. Etest MIC values demonstrated 98% agreement within +/-2 log(2) dilutions compared to the reference broth microdilution method.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20592149      PMCID： PMC2937674          DOI： 10.1128/JCM.00494-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

1.  In vitro antimicrobial activity of doripenem, a new carbapenem.

Authors:  Yigong Ge; Matthew A Wikler; Daniel F Sahm; Renée S Blosser-Middleton; James A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.

Authors:  Ronald N Jones; Holly K Huynh; Douglas J Biedenbach; Thomas R Fritsche; Helio S Sader
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

3.  In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.

Authors:  Sara Marti; Javier Sánchez-Céspedes; Verónica Alba; Jordi Vila
Journal:  Int J Antimicrob Agents       Date:  2008-11-01       Impact factor: 5.283

4.  Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

Authors:  Mariana Castanheira; Ronald N Jones; David M Livermore
Journal:  Diagn Microbiol Infect Dis       Date:  2009-02-26       Impact factor: 2.803
  4 in total
  5 in total

1.  The first case of cholecytitis caused by Aggregatibacter kilianii in Korea.

Authors:  Dahae Yang; Chang-Ki Kim; Junja Park; Na Yeong Song; Yunna Lee; Woonhyoung Lee
Journal:  BMC Infect Dis       Date:  2022-05-26       Impact factor: 3.667

2.  Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.

Authors:  Hansi Kumari; Deepak Balasubramanian; Diansy Zincke; Kalai Mathee
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

3.  Porin involvement in cephalosporin and carbapenem resistance of Burkholderia pseudomallei.

Authors:  Anuwat Aunkham; Albert Schulte; Mathias Winterhalter; Wipa Suginta
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

4.  Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants.

Authors:  Mohamed Elshikh; Syed Ahmed; Scott Funston; Paul Dunlop; Mark McGaw; Roger Marchant; Ibrahim M Banat
Journal:  Biotechnol Lett       Date:  2016-03-11       Impact factor: 2.461

5.  Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli.

Authors:  Dipak Kathayat; Yosra A Helmy; Loic Deblais; Gireesh Rajashekara
Journal:  Sci Rep       Date:  2018-10-17       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.